Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank64
3Y CAGR+13.8%
5Y CAGR+4.1%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+13.8%/yr
vs -5.2%/yr prior
5Y CAGR
+4.1%/yr
Recent acceleration
Acceleration
+19.0pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $37.07M | +213.8% |
| 2024 | $11.81M | -64.7% |
| 2023 | $33.51M | +33.1% |
| 2022 | $25.18M | -43.2% |
| 2021 | $44.35M | +46.1% |
| 2020 | $30.36M | +97.5% |
| 2019 | $15.37M | -50.8% |
| 2018 | $31.21M | +115.7% |
| 2017 | $14.47M | +41.0% |
| 2016 | $10.26M | - |